Skip to main content
. 2020 Mar 7;9(3):727. doi: 10.3390/jcm9030727

Table 2.

General characteristics and PA parameters for AN patients at first study assessment, AN patients at outpatient follow-up and healthy controls °.

Participant Characteristics and PA AN (First Study Assessment)
(n = 25)
AN (Follow-Up)
(n = 25)
Healthy Controls
(n = 20)
Age, years 16.49 (15.08/17.38)
(12.44–17.85)
16.90 (15.49/17.82) b
(12.88–18.20)
15.02 (13.59/15.84) 2
(12.07–17.86)
Height, centimeters 165.4 ± 5.5
(156.3–183.0)
164.9 ± 5.1 a
(156.6–181.3)
165.1 ± 7.1
(153.0–178.0)
Weight, kilograms 41.9 ± 4.4
(35.3– 53.0)
48.3 ± 3.8 b
(41.1–56.6)
57.3 ± 9.4 II 2
(38.8–70.8)
BMI, kilogram/meter2 15.34 ±1.72
(12.80–20.40)
17.87 ± 1.56 b
(14.50–21.80)
20.96 ± 2.88 II 2
(16.00–27.60)
BMI, percentile 2.8 ± 8.9
(0.0–43.0)
13.2 ± 13.7 b
(0.0–61.0)
51.8 ± 25.5 II 2
(7.0–93.0)
Steps 7821 (5948/9296)
(2753–23923)
10475 (8612/14975) a
(646–23273)
11390 (8261/13680)
(4427–23139)
Sedentary behavior (min)
(≥1.1 to ≤ 1.8 METs)
712 (634/760)
(483–868)
681 (636/747)
(499–848)
647 (557/732)
(386–853)
Light PA (min)
(>1.8 and < 3 METs)
103.0 (89.7/155.7)
(41.0–293.0)
90.0 (64.0/117.7) a
(49.0–162.0)
55.0 (41.8/88.1) II 2
(14.0–303.0)
Moderate PA (min)
(≥3 to < 6 METs)
73.0 (35.7/108.7)
(22.0–268.0)
96.0 (73.0/132.3)
(3.0–275.0)
121.5 (82.3/188.2)
(25.0–302.0)
Vigorous PA (min)
(≥6 METs)
1.0 (0.0/3.3)
(0.0–23.0)
13.0 (5.0/33.3) b
(0.0–116.0)
2.0 (0.4/15.8) 1
(0.0–55.0)

° The values are means ± SDs (range) (first quartile/ third quartile). AN, anorexia nervosa; BMI, body mass index; MET, metabolic equivalent of task; PA, physical activity; AN (first study assessment) vs. AN (follow-up): a, p < 0.05; b, p < 0.01; AN (first study assessment) vs. healthy controls: II, p < 0.01; AN (follow-up) vs. healthy controls: 1, p < 0.05; 2, p < 0.01.